Earnings Feed
Start Free
Vistagen Therapeutics, Inc.·4

Jan 3, 5:17 PM ET

Singh Shawn 4

4 · Vistagen Therapeutics, Inc. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2023-12-29
Vistagen Therapeutics, Inc.VTGN
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    Common Stock

    2023-12-29$1.72/sh+167$287→ 5,633 total
Holdings

  • Common Stock

    (indirect: By Trust)
    20,875
Footnotes (1)
  • [F1]Shares purchased pursuant to the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan.

Documents

2 files